A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo
Clinical trial NCT07647237 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07647237
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.